JOSAI UNIVERSITY CORP has a total of 17 patent applications. Its first patent ever was published in 2008. It filed its patents most often in WIPO (World Intellectual Property Organization), China and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and medical technology are CELL MATRIX INC, VHSQUARED LTD and TEGENERO AG.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 6 | |
#2 | China | 3 | |
#3 | EPO (European Patent Office) | 2 | |
#4 | India | 2 | |
#5 | United States | 2 | |
#6 | Republic of Korea | 1 | |
#7 | Taiwan | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Medical technology | |
#4 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Peptides | |
#4 | Electrotherapy | |
#5 | Acyclic or carbocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Shimada Yayoi | 15 |
#2 | Goto Takeshi | 15 |
#3 | Sato Shuji | 15 |
#4 | Ohmori Naoya | 15 |
#5 | Chiang Kueichen | 12 |
#6 | Mori Kenji | 8 |
#7 | Miyagi Takamitsu | 8 |
#8 | Nakano Toshiaki | 5 |
#9 | Goto Shigeru | 5 |
#10 | Hagiwara Satoshi | 4 |
Publication | Filing date | Title |
---|---|---|
WO2013125687A1 | Therapeutic agent for inflammatory disease | |
EP2631246A1 | Monoclonal antibody having immunosuppressive activity or fragment to which antigen thereof is bonded | |
WO2009044555A1 | Preparation and method of administering vaccine and iontophoresis device using the preparation | |
WO2008155920A1 | Drug having effect of promoting hepatocyte growth | |
WO2009004900A1 | Ubiquinone-containing immunoadjuvant | |
WO2009001673A1 | Atp-containing immunoadjuvant |